AU2004212296B2 - Substituted heterocycles - Google Patents
Substituted heterocycles Download PDFInfo
- Publication number
- AU2004212296B2 AU2004212296B2 AU2004212296A AU2004212296A AU2004212296B2 AU 2004212296 B2 AU2004212296 B2 AU 2004212296B2 AU 2004212296 A AU2004212296 A AU 2004212296A AU 2004212296 A AU2004212296 A AU 2004212296A AU 2004212296 B2 AU2004212296 B2 AU 2004212296B2
- Authority
- AU
- Australia
- Prior art keywords
- formula
- hydroxy
- compound
- methyl
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03003495 | 2003-02-14 | ||
| EP03003495.3 | 2003-02-14 | ||
| EP03007594.9 | 2003-04-02 | ||
| EP03007594 | 2003-04-02 | ||
| PCT/EP2004/001097 WO2004071382A2 (en) | 2003-02-14 | 2004-02-06 | Substituted heterocycles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2004212296A1 AU2004212296A1 (en) | 2004-08-26 |
| AU2004212296B2 true AU2004212296B2 (en) | 2010-06-17 |
Family
ID=32870763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004212296A Ceased AU2004212296B2 (en) | 2003-02-14 | 2004-02-06 | Substituted heterocycles |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20060229353A1 (enExample) |
| EP (1) | EP1597262B1 (enExample) |
| JP (1) | JP4795931B2 (enExample) |
| KR (1) | KR20050098928A (enExample) |
| CN (1) | CN1845925B (enExample) |
| AT (1) | ATE448232T1 (enExample) |
| AU (1) | AU2004212296B2 (enExample) |
| BR (1) | BRPI0407234A (enExample) |
| CA (1) | CA2515940C (enExample) |
| DE (1) | DE602004024037D1 (enExample) |
| ES (1) | ES2336562T3 (enExample) |
| IL (1) | IL169897A0 (enExample) |
| IN (1) | IN228043B (enExample) |
| MX (1) | MX272108B (enExample) |
| WO (1) | WO2004071382A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2402045T3 (es) | 2000-11-16 | 2013-04-26 | The Regents Of The University Of California | Taxón de actionomiceto marino para el descubrimiento de fármacos y de productos de fermentación |
| US7176232B2 (en) | 2002-06-24 | 2007-02-13 | The Regents Of The University Of California | Salinosporamides and methods for use thereof |
| US8217072B2 (en) | 2003-06-20 | 2012-07-10 | The Regents Of The University Of California | Salinosporamides and methods for use thereof |
| JP2007523862A (ja) * | 2003-06-20 | 2007-08-23 | ネレアス ファーマシューティカルズ インコーポレイテッド | 癌、炎症及び感染性疾患の治療のための、[3.2.0]複素環式化合物およびそれらの類縁体の使用 |
| WO2005099687A2 (en) * | 2004-04-09 | 2005-10-27 | President And Fellows Of Harvard College | Analogs of salinosporamide a |
| US7579371B2 (en) | 2004-04-30 | 2009-08-25 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| US7276530B2 (en) * | 2004-04-30 | 2007-10-02 | Nereus Pharmaceuticals, Inc. | [3.2.0] Heterocyclic compounds and methods of using the same |
| EP1771411A1 (en) * | 2004-07-12 | 2007-04-11 | Bayer CropScience Aktiengesellschaft | Substituted 2-pyrrolidone derivatives as fungicides and insecticides |
| CN103230394B (zh) | 2004-12-03 | 2016-04-20 | 达纳-法伯癌症研究公司 | 治疗肿瘤性疾病的化合物及其用途 |
| JP2008522975A (ja) * | 2004-12-03 | 2008-07-03 | ネレアス ファーマシューティカルズ インコーポレイテッド | [3.2.0]複素環式化合物及びそれらのアナログを使用する方法 |
| WO2006118973A2 (en) * | 2005-04-29 | 2006-11-09 | Nereus Pharmaceuticals, Inc. | Methods of using heterobyclic compounds for treatment of rectal cancer |
| US7465720B2 (en) | 2005-09-12 | 2008-12-16 | President And Fellows Of Harvard College | Proteasome inhibiting β-lactam compounds |
| NZ596653A (en) | 2006-04-06 | 2012-10-26 | Nereus Pharmaceuticals Inc | Total synthesis of salinosporamide a and analogs thereof |
| WO2008095195A2 (en) * | 2007-02-02 | 2008-08-07 | Nereus Pharmaceuticals, Inc. | Lyophilized formulations of salinosporamide a |
| WO2008137780A2 (en) * | 2007-05-04 | 2008-11-13 | Nereus Pharmaceuticals, Inc. | Use of [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases |
| US8394816B2 (en) * | 2007-12-07 | 2013-03-12 | Irene Ghobrial | Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia |
| EP2088205A1 (en) | 2008-02-11 | 2009-08-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | PSMB10: A diagnosis marker and therapeutic target of chronic rejection. |
| BRPI0909661A2 (pt) | 2008-03-07 | 2015-08-11 | Nereus Pharmaceuticals Inc | Composto e métodos de síntese química e de formação ou preparação de compostos |
| US7910616B2 (en) | 2008-05-12 | 2011-03-22 | Nereus Pharmaceuticals, Inc. | Proteasome inhibitors |
| EP2399129B1 (en) | 2009-02-20 | 2015-11-25 | Michael P. Lisanti | A method of diagnosis or prognosis of a neoplasm comprising determining the level of expression of a protein in stromal cells adjacent to the neoplasm |
| US9126997B1 (en) | 2010-09-07 | 2015-09-08 | Northwestern University | Synergistic effect of glucocorticoid receptor agonists in combination with proteosome inhibitors for treating leukemia and myeloma |
| CA2862580A1 (en) | 2011-10-28 | 2013-05-02 | Millennium Pharmaceuticals, Inc. | Biomarkers of response to nae inhibitors |
| EP2776586B1 (en) | 2011-11-11 | 2018-03-07 | Millennium Pharmaceuticals, Inc. | Biomarkers of response to proteasome inhibitors |
| WO2013112601A1 (en) | 2012-01-24 | 2013-08-01 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
| GB2523211B (en) | 2012-01-27 | 2020-03-18 | Univ Jefferson | MCT protein inhibitor-related prognostic and therapeutic methods |
| US10662477B2 (en) | 2012-10-01 | 2020-05-26 | Millennium Pharmaceuticals, Inc. | Biomarkers and methods to predict response to inhibitors and uses thereof |
| EP2986290A4 (en) | 2013-04-19 | 2017-01-04 | Thomas Jefferson University | Caveolin-1 related methods for treating glioblastoma with temozolomide |
| EP3339291A1 (en) | 2016-12-22 | 2018-06-27 | Vita Api | Proteasome inhibiting ss-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6335358B1 (en) * | 1995-04-12 | 2002-01-01 | President And Fellows Of Harvard College | Lactacystin analogs |
| ES2402045T3 (es) * | 2000-11-16 | 2013-04-26 | The Regents Of The University Of California | Taxón de actionomiceto marino para el descubrimiento de fármacos y de productos de fermentación |
-
2004
- 2004-02-06 KR KR1020057014935A patent/KR20050098928A/ko not_active Abandoned
- 2004-02-06 CA CA2515940A patent/CA2515940C/en not_active Expired - Fee Related
- 2004-02-06 IN IN3350DE2005 patent/IN228043B/en unknown
- 2004-02-06 MX MXPA05008478 patent/MX272108B/es active IP Right Grant
- 2004-02-06 JP JP2006501755A patent/JP4795931B2/ja not_active Expired - Fee Related
- 2004-02-06 EP EP04708731A patent/EP1597262B1/en not_active Expired - Lifetime
- 2004-02-06 ES ES04708731T patent/ES2336562T3/es not_active Expired - Lifetime
- 2004-02-06 CN CN2004800093759A patent/CN1845925B/zh not_active Expired - Fee Related
- 2004-02-06 AT AT04708731T patent/ATE448232T1/de not_active IP Right Cessation
- 2004-02-06 US US10/545,449 patent/US20060229353A1/en not_active Abandoned
- 2004-02-06 WO PCT/EP2004/001097 patent/WO2004071382A2/en not_active Ceased
- 2004-02-06 AU AU2004212296A patent/AU2004212296B2/en not_active Ceased
- 2004-02-06 BR BR0407234-0A patent/BRPI0407234A/pt not_active IP Right Cessation
- 2004-02-06 DE DE602004024037T patent/DE602004024037D1/de not_active Expired - Lifetime
-
2005
- 2005-07-26 IL IL169897A patent/IL169897A0/en unknown
-
2009
- 2009-01-08 US US12/350,696 patent/US20110015248A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2515940A1 (en) | 2004-08-26 |
| IN228043B (enExample) | 2009-02-13 |
| BRPI0407234A (pt) | 2006-01-31 |
| CN1845925A (zh) | 2006-10-11 |
| IN2005DE03350A (enExample) | 2007-06-01 |
| DE602004024037D1 (de) | 2009-12-24 |
| EP1597262A2 (en) | 2005-11-23 |
| WO2004071382A2 (en) | 2004-08-26 |
| ES2336562T3 (es) | 2010-04-14 |
| IL169897A0 (en) | 2007-07-04 |
| CN1845925B (zh) | 2010-11-03 |
| US20060229353A1 (en) | 2006-10-12 |
| HK1096392A1 (en) | 2007-06-01 |
| JP2006517934A (ja) | 2006-08-03 |
| MXPA05008478A (es) | 2005-10-18 |
| MX272108B (es) | 2009-11-25 |
| KR20050098928A (ko) | 2005-10-12 |
| JP4795931B2 (ja) | 2011-10-19 |
| EP1597262B1 (en) | 2009-11-11 |
| ATE448232T1 (de) | 2009-11-15 |
| US20110015248A1 (en) | 2011-01-20 |
| CA2515940C (en) | 2011-12-06 |
| AU2004212296A1 (en) | 2004-08-26 |
| WO2004071382A3 (en) | 2005-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2515940C (en) | Substituted heterocycles | |
| US6673834B2 (en) | Hydroperylene derivatives | |
| AU2004287561B2 (en) | Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer | |
| CA2467249C (en) | Polyene polyketides, processes for their production and their use as pharmaceuticals | |
| ZA200506367B (en) | Substituted heterocycles | |
| EP1633352B1 (en) | Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain | |
| HK1096392B (en) | Substituted heterocycles | |
| AU702777B2 (en) | UCK14 compounds | |
| EP0455818A1 (en) | Proces for the production of substances be-16627 | |
| JPWO1997043434A1 (ja) | 新規生理活性物質及びその製造方法 | |
| US7060821B2 (en) | Osteoclast differentiation inhibitors | |
| CN113825507A (zh) | 具有抗氧化性和神经保护活性的大环化合物 | |
| HK1125410A (en) | Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer | |
| WO1997019104A1 (en) | Cyclopeptolides | |
| HK1098131B (en) | Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer | |
| SK286776B6 (sk) | Amycomycin, spôsob jeho prípravy a farmaceutická kompozícia, ktorá ho obsahuje | |
| JP2005289890A (ja) | ムスカリン性アセチルコリン受容体結合阻害剤 | |
| JPH08119983A (ja) | 新規化合物wf14865、その製造方法およびその用途 | |
| CA2468181A1 (en) | Hydroperylene derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: INTERMED DISCOVERY GMBH Free format text: FORMER APPLICANT(S): BAYER HEALTHCARE AG |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |